The FDA and the Securities and Exchange Commission entered into a Memorandum of Understanding (MOU) to enhance cooperation between the two agencies.
1 report, 1 independent
Updated Aug 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA and the Securities and Exchange Commission entered into a Memorandum of Understanding (MOU) to enhance cooperation between the two agencies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The SEC and FDA formalized interagency cooperation, with the SEC reviewing company filings regarding FDA interactions and market impacts.Sub-event
MOU signed between FDA and SEC to enhance cooperation.1 source
Keep exploring
The entities involved
- FDA
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Industry group supports a rule change while Paul Atkins serves as Chairman of the SEC.
- The SEC censured New York broker dealer OTC Link LLC, with Joshua White serving as Chief Economist and Paul S. Atkins as Chairman.
- Cogent Biosciences plans to submit an NDA to the FDA, with Andrew Robbins as President and CEO.
- The FDA is overseeing a company that is based in the state of Missouri.